PLAY PODCASTS
Virtual EASL 2021: Rapid Audio Recap
Episode 67

Virtual EASL 2021: Rapid Audio Recap

Hear insights from Stefan Zeuzem, MD, on exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Decera Clinical Education Infectious Disease Podcast · Stefan Zeuzem MD

July 19, 202152m 27s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Stefan Zeuzem, MD, discusses exciting new data on viral hepatitis reported at the virtual EASL 2021, including new findings on treatment of HDV, treatment of HBV and HCV in children, linking patients to care, and new molecules being investigated for HBV cure.

Stefan Zeuzem, MD
Professor of Medicine
Chief, Department of Medicine I
JW Goethe University Hospital 
Frankfurt, Germany

Content based on a CME program supported by educational grants provided by AbbVie, Antios Therapeutics, and Gilead Sciences, Inc.

To follow along, download the slides at:
https://bit.ly/3rl8AeS

Link to full program:
https://bit.ly/3ky46QK


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

cure strategiescapsid inhibitorshepatitis c virushepatitis b surface antigen loss na withdrawaljnj-3989hepatocellular carcinoma riskhbsag losshbv nucleos(t)ide analogue discontinuationhbv na treatment discontinuationsi rnashepatitis b surface antigen losshbv tenofovir df withdrawaltenofovir alafenamide hbv perinatal transmissionc-pamshbv hbsag losshepatocellular carcinomavir-3434chronic hepatitis bab-729hbv tdf withdrawaltenofovir alafenamide hbv vertical transmissionledipasvir/sofosbuvirtenofovir df and peginterferon hbveasl 2021ab-836tenofovir alafenamide hbv pregnancyhbv peginterferonhcv people who inject drugschbhbvhcvhcchepatitis b virusgsk3228836